Clinical Trial: Acute Lymphoblastic Leukemia Registry at Asan Medical Center
Study Status: Terminated
Recruit Status: Terminated
Study Type: Observational [Patient Registry]
Official Title: Prospective Observational Cohort Registry for Patients With Acute Lymphoblastic Leukemia at Asan Medical Center
Brief Summary: The investigators would like to propose a prospective longitudinal observational cohort study for patients who will be diagnosed and/or treated for acute lymphoblastic leukemia at Asan Medical Center, Seoul, Korea, to use the acquired data for fundamentals of other retrospective analysis.
Detailed Summary:
- Acquisition of informed concent form
-
Data acquisition from medical record including
- demographic / disease-associated factors
- details of treatment, and its results
- complications during treatment
- genetic data
- survival outcome (upto 10 years)
- Accumulation of data for 30 years
- Use of data for other retrospective analysis (including Asan Medical center Cell Banking basic data)
Sponsor: Asan Medical Center
Current Primary Outcome: Overall survival [ Time Frame: 10 year ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
- Event-free survival [ Time Frame: 10 years ]Definition of events will be as 'relapse', 'death from any cause'. Relapse will be defined as hematologic relapse and molecular relapse, respectively when the patient is diagnosed as Philadelphia-positive acute lymphoblastic leukemia
- Relapse-free survival [ Time Frame: 10 years ]Relapse will be defined as hematologic relapse and molecular relapse, respectively when the patient is diagnosed as Philadelphia-positive acute lymphoblastic leukemia
Original Secondary Outcome: Same as current
Information By: Asan Medical Center
Dates:
Date Received: January 3, 2013
Date Started: January 2013
Date Completion: December 2047
Last Updated: May 22, 2016
Last Verified: May 2016
